Medtronic Had Burden In Device IP Suit, Fed Circ. Told

Law360, Washington (March 6, 2012, 4:32 PM EST) -- A company that licensed two patents for implantable cardiac defibrillators to Boston Scientific Corp. told the Federal Circuit Tuesday that a district court wrongly found Medtronic Inc. did not infringe either patent, saying it was Medtronic's job to prove it wasn't violating the patents.

In March 2011, a Delaware district judge affirmed that the two patents held by Mirowski Family Ventures LLC and licensed to Boston Scientific were valid, but found that Medtronic’s devices, including its InSync, Concerto, Maximo II and Consulta products, did not violate...
To view the full article, register now.